NASDAQ · CERT
Certara, Inc.
$11.20-$0.28 (-2.44%)
Certara, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.
Loading market information…
OTC · PBSV · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pharma-Bio Serv, Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Pharma-Bio Serv, Inc.’s forward annual dividend is $0.08 per share, paid annual. The forward yield is 14.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Pharma-Bio Serv, Inc.’s next earnings report is currently expected on Feb 4, 2027, with estimated earnings per share of $0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pharma-Bio Serv, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jun 16, 2025 | $0.00-86.13% vs estimate | $2.42M-19.43% vs estimate |
|---|
| Q1 2025 | Mar 17, 2025 | $0.00-98.15% vs estimate | $2.47M-8.47% vs estimate |
|---|
| Q4 2024 | Jan 29, 2025 | $0.00-97.67% vs estimate | $2.33M-41.67% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$11.20-$0.28 (-2.44%)
Certara, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.